类风湿性关节炎:旧问题,新的治疗方法
Mahnaz Babaahmadi1,2, Behnoosh Tayebi1,2, Nima Makvand Gholipour2
1Department of Applied Cell Sciences, Faculty of Basic Sciences and Advanced Medical Technologies, Royan Institute, ACECR, Tehran, Iran.
Stem cell research & therapy
|September 23, 2023
概括
介酶体 stromal 细胞 (MSCs) 显示出治疗类风湿性关节炎 (RA),一种慢性自身免疫性疾病的前景. 这些细胞调节免疫系统,为那些对当前治疗无反应的患者提供潜在的新疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 细胞疗法细胞疗法
背景情况:
- 风湿性关节炎 (RA) 是一种慢性,全身性自身免疫性疾病,其特点是关节炎症和潜在的残疾.
- 目前对RA的药物治疗是有限的,有30-40%的患者表现出不充分的反应.
- 确切的RA病因仍然未知,需要新的治疗方法.
研究的目的:
- 审查导致类风湿性关节炎 (RA) 的机制.
- 检查细胞因子和当前药物治疗在RA治疗中的作用.
- 在RA治疗的背景下,讨论介质干细胞 (MSC) 的免疫调节功能.
主要方法:
- 审查有关RA病变的现有文献.
- 对RA中细胞因子参与的分析.
- 检查当前的RA药物治疗方法.
- 探索介质细胞 (MSCs) 和它们的免疫调节性质.
主要成果:
- 介酶体 stromal 细胞 (MSCs) 在调节免疫系统方面表现出显著的潜力.
- 实验研究和临床试验表明MSCs在控制炎症和自身免疫疾病 (如RA) 的有效性.
- 对于那些对传统疗法没有反应的RA患者来说,MSCs提供了一个有希望的途径.
结论:
- 了解MSCs的免疫抑制机制对于其治疗应用至关重要.
- 多样性肌肉细胞是治疗自身免疫性疾病 (包括类风湿性关节炎) 的有希望的工具.
- 对基于MSC的治疗方法的进一步研究可能会彻底改变RA管理.
相关概念视频
01:21Rheumatic Heart Disease III: Medical Management
11
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
164
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
164
01:20Rheumatic Heart Disease IV: Nursing Management
18
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
18
01:29Inflammatory Bowel Disease IV: Pharmacological Management
145
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
145
01:23Rheumatic Heart Disease I: Introduction
14
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
14
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
186
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
186